[HTML][HTML] An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
Targeting SARS-CoV-2 main protease for treatment of COVID-19: Covalent inhibitors structure–activity relationship insights and evolution perspectives
The viral main protease is one of the most attractive targets among all key enzymes involved
in the SARS-CoV-2 life cycle. Covalent inhibition of the cysteine145 of SARS-CoV-2 MPRO …
in the SARS-CoV-2 life cycle. Covalent inhibition of the cysteine145 of SARS-CoV-2 MPRO …
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies
Abstract Coronavirus Disease 2019 (COVID-19), emerged in early December 2019 in China
and became a pandemic situation worldwide by its rapid spread to more than 200 countries …
and became a pandemic situation worldwide by its rapid spread to more than 200 countries …
Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: a randomized clinical trial
BS Abella, EL Jolkovsky, BT Biney… - JAMA internal …, 2021 - jamanetwork.com
Importance Health care workers (HCWs) caring for patients with coronavirus disease 2019
(COVID-19) are at risk of exposure to severe acute respiratory syndrome coronavirus 2 …
(COVID-19) are at risk of exposure to severe acute respiratory syndrome coronavirus 2 …
[HTML][HTML] A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
Many recent studies have investigated the role of either Chloroquine (CQ) or
Hydroxychloroquine (HCQ) alone or in combination with azithromycin (AZM) in the …
Hydroxychloroquine (HCQ) alone or in combination with azithromycin (AZM) in the …
[HTML][HTML] The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
The recent outbreak of the corona virus disease (COVID-19) has had major global impact.
The relationship between severe acute respiratory syndrome coronavirus (SARS-CoV-2) …
The relationship between severe acute respiratory syndrome coronavirus (SARS-CoV-2) …
Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening
Herein, molecular modeling techniques were used with the main goal to obtain candidates
from a drug database as potential targets to be used against SARS-CoV-2. This novel …
from a drug database as potential targets to be used against SARS-CoV-2. This novel …
[HTML][HTML] Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence
Background The triple burden of COVID-19, tuberculosis and human immunodeficiency
virus is one of the major global health challenges of the twenty-first century. In high burden …
virus is one of the major global health challenges of the twenty-first century. In high burden …
[HTML][HTML] COVID-19 infection: the China and Italy perspectives
J Chen, H Lu, G Melino, S Boccia, M Piacentini… - Cell death & …, 2020 - nature.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the
COVID-19 pandemic. Since its first report in December 2019, despite great efforts made in …
COVID-19 pandemic. Since its first report in December 2019, despite great efforts made in …
Safety and effectiveness of azithromycin in patients with COVID-19: an open-label randomised trial
E Sekhavati, F Jafari, SA SeyedAlinaghi… - International journal of …, 2020 - Elsevier
As no specific pharmacological treatment has been validated for use in coronavirus disease
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …